← Leaderboards
Harlan M Krumholz
Yale University
$26,676,336
Attributed
$29,579,711
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.2M · FY2005–18$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$25,584,856 · 4
AHRQ$3,403,262 · 2
FDA$591,593 · 1
By mechanism
R01$19,778,105 · 4
U01$6,398,344 · 2
K12$3,403,262 · 1
Top collaborators
- Jeptha Pelham Curtis4 shared
Most similar at Yale University
Same institution · by research overlap
- Rachel Lampert$7,090,006
- Leora Horwitz$172,853,120
- Isaac Ssinabulya$1,448,509
- Joseph Antony Cafazzo$745,531
- Jeremy Ian Schwartz$1,141,967
Others in their field
Top investigators on “Research Personnel”
- David Heimbrook · Leidos Biomedical Research, Inc.$701,463,488
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Leonard Freedman · Leidos Biomedical Research, Inc.$557,978,666
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David R. Weir · University Of Michigan At Ann Arbor$364,053,504
- Judith S. Currier · University Of California Los Angeles$284,675,012
Research focus
Research PersonnelAmericanHospitalsCaringEnsureHospitalizationCardiologyPhysiciansCollegeMortality Vital StatisticsAcute Myocardial InfarctionCardiovascular SystemPatternUpdateCollaborationsCessation Of LifeAmerican Heart AssociationProgramsMyocardial InfarctionInpatientsMeasurementHealth StatusGuidelinesFuture
Grant awards (30)
Yale-CORE Career Development Program in Patient-Centered Outcomes Research$709,843
K12 · FY2018 · HS · contact PI
Yale-CORE Career Development Program in Patient-Centered Outcomes Research$716,775
K12 · FY2017 · HS · contact PI
Yale-CORE Career Development Program in Patient-Centered Outcomes Research$710,105
K12 · FY2016 · HS · contact PI
Optimizing Medical Device Post-Market Surveillance for Public Value$55,000
U01 · FY2016 · FD · contact PI
Yale-CORE Career Development Program in Patient-Centered Outcomes Research$709,903
K12 · FY2015 · HS · contact PI
Optimizing Medical Device Post-Market Surveillance for Public Value$50,000
U01 · FY2015 · FD · contact PI
Yale-CORE Career Development Program in Patient-Centered Outcomes Research$556,636
K12 · FY2014 · HS · contact PI
Optimizing Medical Device Post-Market Surveillance for Public Value$149,864
U01 · FY2014 · FD · contact PI
Optimizing Medical Device Post-Market Surveillance for Public Value$36,871
U01 · FY2014 · FD · contact PI
Center for Cardiovascular Outcomes Research at Yale University$1,378,060
U01 · FY2013 · HL · contact PI
Optimizing Medical Device Post-Market Surveillance for Public Value$150,000
U01 · FY2013 · FD · contact PI
Center for Cardiovascular Outcomes Research at Yale University$1,445,090
U01 · FY2012 · HL · contact PI
Young Women With Acute Myocardial Infarction$1,007,096
R01 · FY2012 · HL · contact PI
Optimizing Medical Device Post-Market Surveillance for Public Value$149,858
U01 · FY2012 · FD · contact PI
Young Women With Acute Myocardial Infarction$2,402,252
R01 · FY2011 · HL · contact PI
Center for Cardiovascular Outcomes Research at Yale University$1,477,986
U01 · FY2011 · HL · contact PI
Young Women With Acute Myocardial Infarction$2,345,221
R01 · FY2010 · HL · contact PI
Center for Cardiovascular Outcomes Research at Yale University$1,505,615
U01 · FY2010 · HL · contact PI
Young Women With Acute Myocardial Infarction$2,410,890
R01 · FY2008 · HL · contact PI
Telemonitoring to improve heart failure outcomes$1,195,105
R01 · FY2008 · HL · contact PI
Young Women With Acute Myocardial Infarction$2,471,501
R01 · FY2007 · HL · contact PI
Telemonitoring to improve heart failure outcomes$1,770,846
R01 · FY2007 · HL · contact PI
Telemonitoring to improve heart failure outcomes$2,014,503
R01 · FY2006 · HL · contact PI
Telemonitoring to improve heart failure outcomes$53,728
R01 · FY2006 · HL · contact PI
Telemonitoring to improve heart failure outcomes$1,823,141
R01 · FY2005 · HL
Strategies to reduce time to reperfusion therapy for MI$747,318
R01 · FY2005 · HL
Strategies to reduce time to reperfusion therapy for MI$753,142
R01 · FY2004 · HL
Strategies to reduce time to reperfusion therapy for MI$783,362
R01 · FY2003 · HL
HOSPITAL PERFORMANCE &BETA-BLOCKER USE AFTER AMI$0
R01 · FY2001 · HS
HOSPITAL PERFORMANCE &BETA-BLOCKER USE AFTER AMI$0
R01 · FY2000 · HS